CXCL10 and COVID-19: Although less emphasized in pregnant women with COVID-19, our study reveals that both TRAIL and IP-10 levels are elevated in patients within one month of COVID-19 diagnosis compared to those without a diagnosis, indicating a strong inflammatory response in the body.